Publication not explained
Read the Original
This page is a summary of: Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes, Expert Review of Clinical Immunology, November 2010, Taylor & Francis, DOI: 10.1586/eci.10.66.
You can read the full text:
The following have contributed to this page